U.S. Supreme Court Rejects CareDxA’s Appeal in Natera, Inc. (NTRA) False-advertising Dispute
The U.S. Supreme Court declined to hear CareDx's appeal in its false-advertising dispute with Natera, effectively leaving intact a lower-court ruling that favored Natera's marketing claims for its Prospera kidney transplant test. This removes a key legal overhang for NTRA and could strengthen its competitive positioning in the transplant diagnostics market against CareDx.
